1,1-Bis(3′-indolyl)-1-(p-substitutedphenyl)methanes Are Peroxisome Proliferator-Activated Receptor γ Agonists but Decrease HCT-116 Colon Cancer Cell Survival through Receptor-Independent Activation of Early Growth Response-1 and Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1

10.1074/jbc.M101814200

10.1093/carcin/bgh255

10.1124/mol.104.005108

10.1074/jbc.M305295200

10.1124/mol.59.4.901

10.1093/carcin/23.3.425

10.1074/jbc.M208394200

2002, J Nutr, 132, 773, 10.1093/jn/132.4.773

10.1002/jcb.20257

2005, Mol Pharmacol, 68, 119, 10.1124/mol.105.011437

10.1158/0008-5472.CAN-04-0399

10.1073/pnas.86.22.8737

1993, Receptor, 3, 17

10.1194/jlr.M200224-JLR200

10.1093/carcin/20.10.1905

10.1158/0008-5472.CAN-04-3781

10.1046/j.1460-9568.2003.02592.x

10.1210/en.2004-0686

1995, Cancer Res, 55, 5054

10.1006/bbrc.2001.5640

2005, Mol Cancer Ther, 4, 487, 10.1158/1535-7163.MCT-04-0201

10.1053/gast.2002.36364

2004, Biochem Biophys Res Commun, 325, 1298, 10.1016/j.bbrc.2004.10.176

10.1016/j.bbrc.2004.12.138

10.1074/jbc.M909580199

2000, Cancer Res, 60, 5558

1995, Mol Cell Biol, 15, 6262, 10.1128/MCB.15.11.6262

10.1124/mol.63.3.557

2004, Am J Physiol, 287, L201

2001, Cancer Res, 61, 6213

2003, Cancer Res, 63, 958

10.4161/cbt.3.3.544

10.1038/sj.onc.1207819

10.1128/MCB.23.7.2407-2414.2003

1990, J Am Soc Nephrol, 1, 859, 10.1681/ASN.V16859

1987, Oncogene Res, 1, 343

10.1016/S0014-5793(99)00871-6

10.1073/pnas.97.1.109

10.1002/ijc.11173

10.1074/jbc.M408796200